Accuracy Coverage Pricing Contact
Agilent Technologies Inc.

Agilent Technologies Inc. (A)

Agilent Technologies, Inc., incorporated on May 4, 1999, provides application focused solutions that include instruments, software, services and consumables for the entire laboratory workflow. The Company serves the life sciences, diagnostics and applied chemical markets. The Company has three business segments: life sciences and applied markets business, diagnostics and genomics business, and Agilent CrossLab business. The life sciences and applied markets business segment brings together the Company's analytical laboratory instrumentation and informatics. The Company's diagnostics and genomics business segment includes the reagent partnership, pathology, companion diagnostics, genomics and the nucleic acid solutions businesses. The Company's Agilent CrossLab business segment spans the entire lab with its consumables and services portfolio.

The Company’s next-generation sequencing (NGS) library prep solution is Agilent SureSelect, which is a target enrichment research solution that provides total workflow management for laboratories, from QC to target enrichment, to analysis and interpretation. SureSelect is a streamlined, high-sensitivity (HS) solution for research, optimized for labs with a requirement to sequence DNA from formalin-fixed paraffin-embedded (FFPE) samples.

Life Sciences and Applied Markets Business segment

The Company's life sciences and applied markets business segment provides application-focused solutions that include instruments and software that enable customers to identify, quantify and analyze the physical and biological properties of substances and products, as well as enable customers in the clinical and life sciences research areas to interrogate samples at the molecular level. Its product categories include liquid chromatography (LC) systems and components; liquid chromatography mass spectrometry (LCMS) systems; gas chromatography (GC) systems and components; gas chromatography mass spectrometry (GCMS) systems; inductively coupled plasma mass spectrometry (ICP-MS) instruments; atomic absorption (AA) instruments; microwave plasma-atomic emission spectrometry (MP-AES) instruments; inductively coupled plasma optical emission spectrometry (ICP-OES) instruments; laboratory software and informatics systems; laboratory automation and robotic systems; dissolution testing, and vacuum pumps and measurement technologies.

Diagnostics and Genomics Business segment

The Company's diagnostics and genomics business segment consists of approximately three areas of activity providing solutions that include reagents, instruments, software and consumables, which enable customers in the clinical and life sciences research areas to interrogate samples at the cellular and molecular level. Its pathology solutions business is focused on product offerings to cancer diagnostics and anatomic pathology workflows. The portfolio of offerings includes immunohistochemistry (IHC), In Situ Hybridization (ISH), Hematoxylin and Eosin (H&E), staining and special staining. Its genomics business includes arrays for deoxyribonucleic acid (DNA) mutation detection, genotyping, gene copy number determination, identification of gene rearrangements, DNA methylation profiling, gene expression profiling, as well as Next Generation Sequencing (NGS) target enrichment. Its nucleic acid solutions business provides equipment and capability focused on production of synthesized oligonucleotides under pharmaceutical Good Manufacturing Practices (GMP) conditions for use as active pharmaceutical ingredients (API) in a class of drugs that utilize nucleic acid molecules for disease therapy.

Agilent CrossLab Business segment

The Agilent CrossLab business segment's majority of the portfolio is vendor neutral, which means the Company can serve and supply customers regardless of their instrument purchase choices. Its solutions range from chemistries and supplies to services and software helping to connect the entire lab. Its product categories in consumables include GC and LC columns, sample preparation products, custom chemistries and a selection of laboratory instrument supplies. Its services include startup, operational, training and compliance support, as well as asset management and consultative services that rise customer productivity.

Fundamentals

Optimized Dividends

Annual Dividends

Year Amount Change
2006 0.0c
2007 0.0c 0%
2008 0.0c 0%
2009 0.0c 0%
2010 0.0c 0%
2011 0.0c 0%
2012 40.0c 100%
2013 49.2c 23.0%
2014 49.6c 0.8%
2015 41.5c (16.3%)
2016 47.7c 14.9%
2017 54.5c 14.3%
2018 61.1c 12.1%
2019 Login required
2020 Login required
2021 Login required

Dividends

Ex-Div Date Pay Date Year Type Frequency Status Amount
30 Mar 2012 25 Apr 2012 2012 Interim Quarterly Paid 10c
29 Jun 2012 25 Jul 2012 2012 Interim Quarterly Paid 10c
28 Sep 2012 24 Oct 2012 2012 Interim Quarterly Paid 10c
27 Dec 2012 23 Jan 2013 2012 Final Quarterly Paid 10c
28 Mar 2013 24 Apr 2013 2013 Interim Quarterly Paid 12c
28 Jun 2013 24 Jul 2013 2013 Interim Quarterly Paid 12c
27 Sep 2013 23 Oct 2013 2013 Interim Quarterly Paid 12c
27 Dec 2013 22 Jan 2014 2013 Final Quarterly Paid 13.2c
09 Apr 2014 23 Apr 2014 2014 Interim Quarterly Paid 13.2c
27 Jun 2014 23 Jul 2014 2014 Interim Quarterly Paid 13.2c
26 Sep 2014 22 Oct 2014 2014 Interim Quarterly Paid 13.2c
02 Jan 2015 28 Jan 2015 2014 Final Quarterly Paid 10c
27 Mar 2015 22 Apr 2015 2015 Interim Quarterly Paid 10c
26 Jun 2015 22 Jul 2015 2015 Interim Quarterly Paid 10c
25 Sep 2015 21 Oct 2015 2015 Interim Quarterly Paid 10c
31 Dec 2015 27 Jan 2016 2015 Final Quarterly Paid 11.5c
01 Apr 2016 27 Apr 2016 2016 Interim Quarterly Paid 11.5c
30 Jun 2016 27 Jul 2016 2016 Interim Quarterly Paid 11.5c
30 Sep 2016 26 Oct 2016 2016 Interim Quarterly Paid 11.5c
29 Dec 2016 25 Jan 2017 2016 Final Quarterly Paid 13.2c
31 Mar 2017 26 Apr 2017 2017 Interim Quarterly Paid 13.2c
29 Jun 2017 26 Jul 2017 2017 Interim Quarterly Paid 13.2c
02 Oct 2017 25 Oct 2017 2017 Interim Quarterly Paid 13.2c
29 Dec 2017 24 Jan 2018 2017 Final Quarterly Paid 14.9c
02 Apr 2018 25 Apr 2018 2018 Interim Quarterly Paid 14.9c
02 Jul 2018 25 Jul 2018 2018 Interim Quarterly Paid 14.9c
01 Oct 2018 24 Oct 2018 2018 Interim Quarterly Paid 14.9c
28 Dec 2018 23 Jan 2019 2018 Final Quarterly Paid 16.4c
01 Apr 2019 24 Apr 2019 2019 Interim Quarterly Paid 16.4c
01 Jul 2019 24 Jul 2019 2019 Interim Quarterly Paid 16.4c
Login Login 2019 Interim Quarterly Forecast Login
Login Login 2019 Final Quarterly Forecast Login
Login Login 2020 Interim Quarterly Forecast Login
Login Login 2020 Interim Quarterly Forecast Login
Login Login 2020 Interim Quarterly Forecast Login
Login Login 2020 Final Quarterly Forecast Login
Login Login 2021 Interim Quarterly Forecast Login
Login Login 2021 Interim Quarterly Forecast Login
Login Login 2021 Interim Quarterly Forecast Login
Login Login 2021 Final Quarterly Forecast Login

Agilent Technologies Inc. optimized dividend - 12 month history

Optimized dividend graph demo

Agilent Technologies Inc. share price - 12 month history

You're currently viewing outdated and/or artificial data.

Try the real thing now:

Activate Free Trial